Head-To-Head Spine Fracture PMMA Trials Urged By FDA Guidance
This article was originally published in The Gray Sheet
Executive Summary
Two-year follow-up of patients in concurrent, randomized, controlled studies of PMMA-based bone cements for spinal insufficiency fractures is recommended by FDA to support 510(k) submissions